Terpenoids mediated cell apoptotsis in cervical cancer: Mechanisms, advances and prospects

Peng Zhang1, Hong Liu1, Yuan Yu1

  • 1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan Province, China.

Fitoterapia
|December 4, 2024
PubMed
Abstract

Insights

Terpenoids show promise in preventing cervical cancer by promoting cancer cell death and enhancing chemotherapy effectiveness. Further research is needed to explore their full therapeutic potential and clinical applications.

Area of Science:

  • Natural Products Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Cervical cancer is a leading global malignancy, particularly in developing nations.
  • Existing prevention strategies like vaccination and screening have limitations.
  • High incidence necessitates novel therapeutic and prophylactic approaches.

Purpose of the Study:

  • To systematically review terpenoids for cervical cancer prevention.
  • To elucidate terpenoid mechanisms in cervical cancer prophylaxis and treatment.
  • To identify limitations in current research on terpenoids for cervical cancer.

Main Methods:

  • Systematic literature review of studies on terpenoids and cervical cancer.
  • Analysis of identified terpenoids' mechanisms of action.
  • Evaluation of current research limitations and future directions.

Main Results:

  • Terpenoids reduce cervical cancer incidence and induce cancer cell apoptosis.
  • Mechanisms involve PI3K/AKT, endoplasmic reticulum stress (ERS), and mitochondria-dependent pathways.
  • Some terpenoids improve chemotherapy sensitivity and patient quality of life.

Conclusions:

  • Terpenoids significantly inhibit cervical cancer progression.
  • Diverse terpenoids exhibit complex mechanisms requiring further investigation.
  • Clinical trials and applications can be advanced by understanding specific targets and bioactivities.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K